PSI Journal Club: Group Sequential Designs

Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars

Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.

AIMS SIG - Open-Source Lunch Bites

Topic: R Package Basics. Our monthly webinar series allows attendees to gain practical knowledge and skills in open-source coding and tools, with a focus on applications in the pharmaceutical industry. This month’s session, “R Package Basics,” will introduce the fundamentals of working with R packages—covering how to install, load, and manage them effectively to support data analysis and reproducible research. The session will provide a solid starting point, clarify common misconceptions, and offer valuable resources for continued learning.

PSI Mentoring 2026

Date: Ongoing 6 month cycle beginning late April/early May 2026 Are you a member of PSI looking to further your career or help develop others - why not sign up to the PSI Mentoring scheme? You can expand your network, improve your leadership skills and learn from more senior colleagues in the industry.

PSI Book Club Lunch and Learn: Communicating with Clarity and Confidence

If you have read Ros Atkins’ book The Art of Explanation or want to listen to the BBC’s ‘Communicator in Chief’, you are invited to join the PSI Book Club Lunch and Learn, to discuss the content and application with the author, Ros Atkins. Having written the book within the context of the news industry, Ros is keen to hear how we have applied the ideas as statisticians within drug development and clinical trials. There will be dedicated time during the webinar to ASK THE AUTHOR any questions – don’t miss out on this exclusive PSI Book Club event! Haven’t read the book yet? Pick up a copy today and join us. Explanation - identifying and communicating what we want to say - is described as an art, in the title of his book. However, the creativity comes from Ros’ discernment in identifying and describing a clear step-by-step process to follow and practice. Readers can learn Ros’ rules, developed and polished throughout his career as a journalist, to help communicate complex written or spoken information clearly.

PSI Training Course: Effective Leadership – the keys to growing your leadership capabilities

This course will consist of three online half-day workshops. The first will be aimed at building trust, the backbone of leadership and a key to becoming effective. This is key to building a solid foundation. The second will be on improving communication as a technical leader. This workshop will focus on communication strategies for different stakeholders and will involve tips on effective communication and how to develop the skills of active listening, coaching and what improv can teach us about good communication. The final workshop will bring these two components together to help leaders become more influential. This will also focus on how to use Steven Covey’s 7-Habits, in particular Habits 4, 5 and 6, which are called the habits of communication. The workshops will be interactive, allowing you to practice the concepts discussed. There will be plenty of time for questions and discussion. There will also be reflective time where you can think about what you are learning and how you might experiment with it.

Speaker	Biography
Jenny Devenport	A Ph.D. statistician by training, Jenny Devenport has more than 20 years of experience driving decisions in the healthcare industry including device /pharmaceutical development, quality monitoring and program evaluation in public health, and practice management in occupational healthcare systems. She aims to ask the right questions and develop optimal solutions to get patients the best care. She champions scientific curiosity, use of diverse data sources, effective measurement, and meticulous study design. As a leader and coach, she gets people to exceed themselves by leaving their comfort zones, appreciating their strengths, building strategic collaborations, forming extensive personal networks, and aiming for impact locally and globally.
Andy Grieve	Andrew P. Grieve is a Visiting Professor at King’s College London having recently retired from the position of Research Fellow in the Statistical Innovation group at UCB Pharma. He is a former Chair of PSI (Statisticians in the Pharmaceutical Industry) and a past-President of the Royal Statistical Society. He has over 45 years of experience as a biostatistician working in the pharmaceutical industry and academia. He has been active in the majority of areas of pharmaceutical R&D in which statistical methods and statisticians are intimately involved including drug discovery, pre-clinical toxicology, pharmaceutical development, pharmacokinetics and pharmacodynamics, phase I-IV of clinical development, manufacturing, health economics and clinical operations. Since the early 1980s he has promoted the use of Bayesian methods in pharmaceutical R&D and his statistical research has been primarily concerned with the implementation of Bayesian ideas and techniques. Latterly he has concentrated on the design and implementation of Bayesian adaptive trials, and the Probability of Success (PoS) of studies and drug development programs. He has published over 140 articles and is the author of two books. He has been an invited speaker at national and international conferences on over 300 occasions.
Zhiwei Zhang	Zhiwei Zhang is a senior director at Gilead Sciences. Before joining Gilead, he worked in academia and government agencies, including FDA and NIH. His research interests include causal inference and clinical trial design and analysis. Dr. Zhang has published over 100 research articles, mostly in statistical journals. He is an elected fellow of the American Statistical Association.

Speaker	Biography
Jenny Devenport	A Ph.D. statistician by training, Jenny Devenport has more than 20 years of experience driving decisions in the healthcare industry including device /pharmaceutical development, quality monitoring and program evaluation in public health, and practice management in occupational healthcare systems. She aims to ask the right questions and develop optimal solutions to get patients the best care. She champions scientific curiosity, use of diverse data sources, effective measurement, and meticulous study design. As a leader and coach, she gets people to exceed themselves by leaving their comfort zones, appreciating their strengths, building strategic collaborations, forming extensive personal networks, and aiming for impact locally and globally.
Andy Grieve	Andrew P. Grieve is a Visiting Professor at King’s College London having recently retired from the position of Research Fellow in the Statistical Innovation group at UCB Pharma. He is a former Chair of PSI (Statisticians in the Pharmaceutical Industry) and a past-President of the Royal Statistical Society. He has over 45 years of experience as a biostatistician working in the pharmaceutical industry and academia. He has been active in the majority of areas of pharmaceutical R&D in which statistical methods and statisticians are intimately involved including drug discovery, pre-clinical toxicology, pharmaceutical development, pharmacokinetics and pharmacodynamics, phase I-IV of clinical development, manufacturing, health economics and clinical operations. Since the early 1980s he has promoted the use of Bayesian methods in pharmaceutical R&D and his statistical research has been primarily concerned with the implementation of Bayesian ideas and techniques. Latterly he has concentrated on the design and implementation of Bayesian adaptive trials, and the Probability of Success (PoS) of studies and drug development programs. He has published over 140 articles and is the author of two books. He has been an invited speaker at national and international conferences on over 300 occasions.
Zhiwei Zhang	Zhiwei Zhang is a senior director at Gilead Sciences. Before joining Gilead, he worked in academia and government agencies, including FDA and NIH. His research interests include causal inference and clinical trial design and analysis. Dr. Zhang has published over 100 research articles, mostly in statistical journals. He is an elected fellow of the American Statistical Association.

Speaker	Biography
Jenny Devenport	A Ph.D. statistician by training, Jenny Devenport has more than 20 years of experience driving decisions in the healthcare industry including device /pharmaceutical development, quality monitoring and program evaluation in public health, and practice management in occupational healthcare systems. She aims to ask the right questions and develop optimal solutions to get patients the best care. She champions scientific curiosity, use of diverse data sources, effective measurement, and meticulous study design. As a leader and coach, she gets people to exceed themselves by leaving their comfort zones, appreciating their strengths, building strategic collaborations, forming extensive personal networks, and aiming for impact locally and globally.
Andy Grieve	Andrew P. Grieve is a Visiting Professor at King’s College London having recently retired from the position of Research Fellow in the Statistical Innovation group at UCB Pharma. He is a former Chair of PSI (Statisticians in the Pharmaceutical Industry) and a past-President of the Royal Statistical Society. He has over 45 years of experience as a biostatistician working in the pharmaceutical industry and academia. He has been active in the majority of areas of pharmaceutical R&D in which statistical methods and statisticians are intimately involved including drug discovery, pre-clinical toxicology, pharmaceutical development, pharmacokinetics and pharmacodynamics, phase I-IV of clinical development, manufacturing, health economics and clinical operations. Since the early 1980s he has promoted the use of Bayesian methods in pharmaceutical R&D and his statistical research has been primarily concerned with the implementation of Bayesian ideas and techniques. Latterly he has concentrated on the design and implementation of Bayesian adaptive trials, and the Probability of Success (PoS) of studies and drug development programs. He has published over 140 articles and is the author of two books. He has been an invited speaker at national and international conferences on over 300 occasions.
Zhiwei Zhang	Zhiwei Zhang is a senior director at Gilead Sciences. Before joining Gilead, he worked in academia and government agencies, including FDA and NIH. His research interests include causal inference and clinical trial design and analysis. Dr. Zhang has published over 100 research articles, mostly in statistical journals. He is an elected fellow of the American Statistical Association.

Speaker	Biography
Jenny Devenport	A Ph.D. statistician by training, Jenny Devenport has more than 20 years of experience driving decisions in the healthcare industry including device /pharmaceutical development, quality monitoring and program evaluation in public health, and practice management in occupational healthcare systems. She aims to ask the right questions and develop optimal solutions to get patients the best care. She champions scientific curiosity, use of diverse data sources, effective measurement, and meticulous study design. As a leader and coach, she gets people to exceed themselves by leaving their comfort zones, appreciating their strengths, building strategic collaborations, forming extensive personal networks, and aiming for impact locally and globally.
Andy Grieve	Andrew P. Grieve is a Visiting Professor at King’s College London having recently retired from the position of Research Fellow in the Statistical Innovation group at UCB Pharma. He is a former Chair of PSI (Statisticians in the Pharmaceutical Industry) and a past-President of the Royal Statistical Society. He has over 45 years of experience as a biostatistician working in the pharmaceutical industry and academia. He has been active in the majority of areas of pharmaceutical R&D in which statistical methods and statisticians are intimately involved including drug discovery, pre-clinical toxicology, pharmaceutical development, pharmacokinetics and pharmacodynamics, phase I-IV of clinical development, manufacturing, health economics and clinical operations. Since the early 1980s he has promoted the use of Bayesian methods in pharmaceutical R&D and his statistical research has been primarily concerned with the implementation of Bayesian ideas and techniques. Latterly he has concentrated on the design and implementation of Bayesian adaptive trials, and the Probability of Success (PoS) of studies and drug development programs. He has published over 140 articles and is the author of two books. He has been an invited speaker at national and international conferences on over 300 occasions.
Zhiwei Zhang	Zhiwei Zhang is a senior director at Gilead Sciences. Before joining Gilead, he worked in academia and government agencies, including FDA and NIH. His research interests include causal inference and clinical trial design and analysis. Dr. Zhang has published over 100 research articles, mostly in statistical journals. He is an elected fellow of the American Statistical Association.

Speaker	Biography
Jenny Devenport	A Ph.D. statistician by training, Jenny Devenport has more than 20 years of experience driving decisions in the healthcare industry including device /pharmaceutical development, quality monitoring and program evaluation in public health, and practice management in occupational healthcare systems. She aims to ask the right questions and develop optimal solutions to get patients the best care. She champions scientific curiosity, use of diverse data sources, effective measurement, and meticulous study design. As a leader and coach, she gets people to exceed themselves by leaving their comfort zones, appreciating their strengths, building strategic collaborations, forming extensive personal networks, and aiming for impact locally and globally.
Andy Grieve	Andrew P. Grieve is a Visiting Professor at King’s College London having recently retired from the position of Research Fellow in the Statistical Innovation group at UCB Pharma. He is a former Chair of PSI (Statisticians in the Pharmaceutical Industry) and a past-President of the Royal Statistical Society. He has over 45 years of experience as a biostatistician working in the pharmaceutical industry and academia. He has been active in the majority of areas of pharmaceutical R&D in which statistical methods and statisticians are intimately involved including drug discovery, pre-clinical toxicology, pharmaceutical development, pharmacokinetics and pharmacodynamics, phase I-IV of clinical development, manufacturing, health economics and clinical operations. Since the early 1980s he has promoted the use of Bayesian methods in pharmaceutical R&D and his statistical research has been primarily concerned with the implementation of Bayesian ideas and techniques. Latterly he has concentrated on the design and implementation of Bayesian adaptive trials, and the Probability of Success (PoS) of studies and drug development programs. He has published over 140 articles and is the author of two books. He has been an invited speaker at national and international conferences on over 300 occasions.
Zhiwei Zhang	Zhiwei Zhang is a senior director at Gilead Sciences. Before joining Gilead, he worked in academia and government agencies, including FDA and NIH. His research interests include causal inference and clinical trial design and analysis. Dr. Zhang has published over 100 research articles, mostly in statistical journals. He is an elected fellow of the American Statistical Association.

Past PSI Events

On this page:

Conferences